Wei Kuo-Liang, Chou Jian-Liang, Chen Yin-Chen, Low Jie-Ting, Lin Guan-Ling, Liu Jing-Lan, Chang Te-Sheng, Chen Wei-Ming, Hsieh Yung-Yu, Yan Pearlly S, Chuang Yu-Ming, Lin Jora M J, Wu Shu-Fen, Chiang Ming-Ko, Li Chin, Wu Cheng-Shyong, Chan Michael W Y
Division of Gastroenterology, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Department of Biomedical Sciences, National Chung Cheng University, Chiayi, Taiwan.
Front Oncol. 2021 Feb 25;11:575667. doi: 10.3389/fonc.2021.575667. eCollection 2021.
The purpose of this study was to identify genes that were epigenetically silenced by STAT3 in gastric cancer.
MBDcap-Seq and expression microarray were performed to identify genes that were epigenetically silenced in AGS gastric cancer cell lines depleted of STAT3. Cell lines and animal experiments were performed to investigate proliferation and metastasis of miR-193a and YWHAZ in gastric cancer cell lines. Bisulfite pyrosequencing and tissue microarray were performed to investigate the promoter methylation of miR-193a and expression of STAT3, YWHAZ in patients with gastritis (n = 8) and gastric cancer (n = 71). Quantitative methylation-specific PCR was performed to examine miR-193a promoter methylation in cell-free DNA of serum samples in gastric cancer patients (n = 19).
As compared with parental cells, depletion of STAT3 resulted in demethylation of a putative STAT3 target, miR-193a, in AGS gastric cancer cells. Although bisulfite pyrosequencing and epigenetic treatment confirmed that miR-193a was epigenetically silenced in gastric cancer cell lines, ChIP-PCR found that it may be indirectly affected by STAT3. Ectopic expression of miR-193a in AGS cells inhibited proliferation and migration of gastric cancer cells. Further expression microarray and bioinformatics analysis identified YWHAZ as one of the target of miR-193a in AGS gastric cancer cells, such that depletion of YWHAZ reduced migration in AGS cells, while its overexpression increased invasion in MKN45 cells and . Clinically, bisulfite pyrosequencing revealed that promoter methylation of miR-193a was significantly higher in human gastric cancer tissues (n = 11) as compared to gastritis (n = 8, p < 0.05). Patients infected with H. pylori showed a significantly higher miR-193a methylation than those without H. pylori infection (p < 0.05). Tissue microarray also showed a positive trend between STAT3 and YWHAZ expression in gastric cancer patients (n = 60). Patients with serum miR-193a methylation was associated with shorter overall survival than those without methylation (p < 0.05).
Constitutive activation of JAK/STAT signaling may confer epigenetic silencing of the STAT3 indirect target and tumor suppressor microRNA, miR-193a in gastric cancer. Transcriptional suppression of miR-193a may led to overexpression of YWHAZ resulting in tumor progression. Targeted inhibition of STAT3 may be a novel therapeutic strategy against gastric cancer.
本研究旨在鉴定在胃癌中被信号转导和转录激活因子3(STAT3)表观遗传沉默的基因。
进行甲基化DNA结合蛋白捕获测序(MBDcap-Seq)和表达微阵列分析,以鉴定在STAT3缺失的AGS胃癌细胞系中表观遗传沉默的基因。进行细胞系和动物实验,以研究miR-193a和14-3-3ζ(YWHAZ)在胃癌细胞系中的增殖和转移情况。进行亚硫酸氢盐焦磷酸测序和组织微阵列分析,以研究miR-193a的启动子甲基化以及STAT3、YWHAZ在胃炎患者(n = 8)和胃癌患者(n = 71)中的表达。进行定量甲基化特异性PCR,以检测胃癌患者(n = 19)血清样本游离DNA中miR-193a启动子甲基化情况。
与亲本细胞相比,STAT3缺失导致AGS胃癌细胞中一个假定的STAT3靶标miR-193a去甲基化。尽管亚硫酸氢盐焦磷酸测序和表观遗传处理证实miR-193a在胃癌细胞系中表观遗传沉默,但染色质免疫沉淀PCR(ChIP-PCR)发现它可能受STAT3间接影响。miR-193a在AGS细胞中的异位表达抑制了胃癌细胞的增殖和迁移。进一步的表达微阵列和生物信息学分析确定YWHAZ是AGS胃癌细胞中miR-193a的靶标之一,因此YWHAZ缺失减少了AGS细胞的迁移,而其过表达增加了MKN45细胞的侵袭。临床上,亚硫酸氢盐焦磷酸测序显示,与胃炎组织(n = 8)相比(p < 0.05),人胃癌组织(n = 11)中miR-193a的启动子甲基化显著更高。感染幽门螺杆菌的患者miR-193a甲基化显著高于未感染幽门螺杆菌的患者(p < 0.05)。组织微阵列还显示胃癌患者(n = 60)中STAT3和YWHAZ表达之间呈正相关趋势。血清miR-193a甲基化的患者总生存期短于未甲基化的患者(p < 0.05)。
JAK/STAT信号通路的组成性激活可能导致胃癌中STAT3间接靶标及肿瘤抑制性微小RNA miR-193a的表观遗传沉默。miR-193a的转录抑制可能导致YWHAZ过表达,从而导致肿瘤进展。靶向抑制STAT3可能是一种新型的胃癌治疗策略。